Transparency Market Research

Orthobiologics Market to Be Driven by Rising Prevalence of Chronic Arthritis and Rapidly Aging World Population

Transparency Market Research Report Added "Orthobiologics Market (Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019"


Albany, NY -- (SBWIRE) -- 01/16/2017 -- The market for orthobiologics is gaining increasing attention owing to the compelling benefits of these substances in expediting skeletal and tissue healing. The numerous limitations faced by allografts and autografts in the field of skeletal and tissue healing are further compelling medical practitioners to adopt orthobiologics at an increasing rate. While the rising demand for musculoskeletal procedures in the recent years has led to a substantial boost to the global orthobiologics market in recent times, the lack of effective reimbursement policies and rigorous regulations are limiting adoption of orthobiologics to a certain extent.

View Exclusive Global Strategic Business Report:

The report examines the various aspects of the global orthobiologics market in great detail. Each of the segments of the market is analyzed from a global as well as regional standpoint. The implications of the regulatory framework, key regulations, and policies on a variety of decisions are also studied.

The report incorporates data gathered with the help of a number of primary and secondary research methodologies and relies upon numerous industry-best analytical methods for deriving the most insightful market analysis from the data gathered. With the voluminous information in the report, it forms a valuable asset for managers, business strategists, and all other decision makers who are interested in the overall development of the global orthobiologics market.

The report states that the global market for orthobiologics will expand at a 5.9% CAGR between 2013 and 2019. As such, the market, which had a valuation of US$3.7 bn in 2012, will rise to US$5.5 bn by 2019.

The report segments the global market for orthobiologics on the basis of three broad criteria: product types, key applications, and key regional markets. Based on the type of products, the market is segmented into bone morphogenetic proteins, allografts, viscosupplementation, synthetic bone substitutes, demineralized bone matrix (DBM), stem cell therapy, and machined bones. Based on the key applications of orthobiologics, the market is segmented into reconstructive surgery, trauma, and spinal fusion. Key regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World (RoW).

Of the key product types in the global orthobiologics market studied in the report, the report states that the market for viscosupplementation acquired the largest share in the market in 2012 owing to the mounting global demand for knee treatments. Viscosupplementation is considered a more effective painkiller than NSAIDS. The market for orthobiologics is also expected to significantly benefit from the growing demand for stem cell therapies in the near future.

Of the key regional markets, the market is currently gaining the most from the regional markets of Europe and North America owing to the high prevalence of arthritis and obesity in these regions. Over the report's forecast period, however, the market is expected to see the fastest growth in Asia Pacific in response to the rising geriatric population base in the region.

The report presents a detailed overview of the competitive landscape of the global orthobiologics market, wherein it studies the detailed business profiles of some of the key businesses operating in the market. Some of the key businesses operating in the market are Alphatec Spine, Inc., Globus Medical, Inc., DePuy Synthes, Inc., Bacterin International, Inc., Medtronic, Inc., Integra LifeSciences Corporation, Zimmer Holdings, Inc., Exactech, Inc., and Biomet, Inc.

About Transparency Market Research
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453